His lab is working on refining the alanine-scanning assay to a couple critical residues that can precisely distinguish amongst fibrils from neurodegenerative tauopathies. He envisions making use of this streamlined assay for postmortem neuropathological diagnosis, And maybe for blood screening of tauopathies.The variables that ascertain regardless